KISIMA Trademark
Trademark Overview
On Wednesday, August 24, 2016, a trademark application was filed for KISIMA with the United States Patent and Trademark Office. The USPTO has given the KISIMA trademark a serial number of 87149001. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 25, 2025. This trademark is owned by AMAL Therapeutics SA. The KISIMA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical, medical and veterinary preparations, namely, proteins, peptides, and modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules, namely, peptides, proteins, nucleic acids and derivatives of peptides, proteins, and nucleic acids for medical and pharmaceutical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; diagnostic preparations for medical and veterinary use; biological preparations, namely, proteins, peptides, modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; cells for medical purposes; pharmaceutical preparations and compositio...
Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins used in industry and science, in particular peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins for industrial and scientific purposes, all the foregoing being chemical preparations for industrial and scientific use; biochemical products, in the nature of biochemical preparations and substances for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes, namely, biochemical peptide substrates for laboratory or research use; proteins for use in science, industry and manufacture; biological preparations, namely, cell cultures, tissue cultures; chemical reagents containing peptides, proteins, modified peptides, modified proteins...
Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services, namely, pest control for agriculture, horticulture and forestry, farming services in the field of grain; Pharmaceutical services, namely, pharmaceutical advice, pharmaceutical compounding services; Medical information
Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and research services in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to science; medical product and pharmaceutical research and development services; biological scientific research and development and clinical scientific research and development services; research and development services all relating to industry in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products a...
General Information
| Serial Number | 87149001 |
| Word Mark | KISIMA |
| Filing Date | Wednesday, August 24, 2016 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, April 25, 2025 |
| Registration Number | 5577986 |
| Registration Date | Tuesday, October 9, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 24, 2018 |
Trademark Statements
| Goods and Services | Pharmaceutical, medical and veterinary preparations, namely, proteins, peptides, and modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins and derivatives of peptides and proteins as well as protein- and peptide-pools for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules, namely, peptides, proteins, nucleic acids and derivatives of peptides, proteins, and nucleic acids for medical and pharmaceutical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; diagnostic preparations for medical and veterinary use; biological preparations, namely, proteins, peptides, modified peptides for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; cells for medical purposes; pharmaceutical preparations and compositions, namely, pharmaceutical preparations and compositions for the treatment and prevention of cancer; nucleic acids, in particular recombinant nucleic acids; nucleic acids for medical purposes, namely, for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; nucleic acid sequences for medical purposes, namely, for diagnostic purposes and the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; proteins for medical purposes, namely, for diagnostic purposes and for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; macromolecules and biologically active substances for medical purposes for the treatment and prevention of tumor and cancer diseases, infectious diseases, and autoimmune diseases; kits containing preparations for medical purposes, comprised primarily of pharmaceutical preparations for the treatment and prevention of tumor and cancer diseases, and pharmaceutical preparations namely, proteins, peptides, modified peptides for the treatment and prevention of infectious diseases, and autoimmune diseases |
| Translation of Words in Mark | The English translation of "KISIMA" in the mark is "WATER WELL". |
| Goods and Services | Peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins used in industry and science, in particular peptides, proteins, modified peptides and proteins and derivatives of peptides and proteins for industrial and scientific purposes, all the foregoing being chemical preparations for industrial and scientific use; biochemical products, in the nature of biochemical preparations and substances for analyses in laboratories; diagnostic preparations containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific purposes; peptide substrates for scientific purposes, namely, biochemical peptide substrates for laboratory or research use; proteins for use in science, industry and manufacture; biological preparations, namely, cell cultures, tissue cultures; chemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes and biochemical reagents containing peptides, proteins, modified peptides, modified proteins, derivatives of peptides, derivatives of proteins, nucleic acids, derivatives of nucleic acids, or cells for scientific and research purposes; nucleic acids, in particular recombinant nucleic acids; nucleic acids for scientific purposes; nucleic acid sequences; biological active peptides for scientific and research purposes; antisera for scientific and industrial purposes; all above other than for medical and veterinary use |
| Goods and Services | Medical services; Veterinary services; Hygienic and beauty care for human beings or animals; Agriculture, horticulture and forestry services, namely, pest control for agriculture, horticulture and forestry, farming services in the field of grain; Pharmaceutical services, namely, pharmaceutical advice, pharmaceutical compounding services; Medical information |
| Goods and Services | Scientific and technological services and research and design relating thereto, namely, scientific research, analysis and testing in the field of pharmaceuticals, medicine, biochemistry and biotechnology, and design of biochemical macromolecules, in particular proteins, peptides and nucleic acids, and biochemical preparations for scientific, medical and industrial use; Industrial analysis and research services in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to science; medical product and pharmaceutical research and development services; biological scientific research and development and clinical scientific research and development services; research and development services all relating to industry in the field of pharmaceuticals, medicine, biochemistry and biotechnology; research and development services all relating to biochemistry and biotechnology; research and development services all relating to products and tools to be used in biotechnical, biochemical, medical and pharmaceutical research; medical and pharmacological research services; medical research; scientific research for medical purposes; laboratory research services in the field of protein, peptide and molecular biology; provision of information and data relating to medical product and scientific research and development; medical and pharmaceutical product development and evaluation; Pharmaceutical, medical, biotechnological and biochemical research and development services for the pharmaceutical industry; Information technology services for the pharmaceutical and healthcare industries, namely, planning, design and management of information technology systems, consulting in the field of information technology, design and development of computer software |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, April 25, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | AMAL Therapeutics SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Geneva 1205
CH |
| Party Name | AMAL Therapeutics SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Geneva 1205
CH |
| Party Name | AMAL Therapeutics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Geneva 1205
CH |
Trademark Events
| Event Date | Event Description |
| Tuesday, May 16, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, August 27, 2016 | NEW APPLICATION ENTERED |
| Monday, August 29, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 5, 2016 | ASSIGNED TO EXAMINER |
| Wednesday, December 7, 2016 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 7, 2016 | NON-FINAL ACTION E-MAILED |
| Wednesday, December 7, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 20, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 12, 2017 | ASSIGNED TO LIE |
| Tuesday, May 16, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 20, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 8, 2017 | SUSPENSION LETTER WRITTEN |
| Thursday, June 8, 2017 | LETTER OF SUSPENSION E-MAILED |
| Thursday, June 8, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Sunday, November 26, 2017 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, November 28, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 28, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 20, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 20, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, June 11, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 4, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 9, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Monday, October 9, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, April 25, 2025 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, July 24, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, June 11, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 18, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 18, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, June 20, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 24, 2018 | PUBLISHED FOR OPPOSITION |
